Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention

医学 经皮冠状动脉介入治疗 传统PCI 队列 内科学 弗雷明翰风险评分 心肌梗塞 外科 疾病
作者
Felice Gragnano,David V. Klaveren,Dik Heg,Lorenz Räber,Mitchell W. Krucoff,Sergio Raposeiras‐Roubín,Jurriën M. ten Berg,Sergio Leonardi,Takeshi Kimura,Noé Corpataux,Alessandro Spirito,James Bernard Hermiller,Emad Abu‐Assi,Dean R.P.P. Chan Pin Yin,Jaouad Azzahhafi,Claudio Montalto,Marco Galazzi,Sarah Bär,Raminta Kavaliauskaite,Fabrizio D’Ascenzo
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:151 (6): 343-355 被引量:108
标识
DOI:10.1161/circulationaha.124.072009
摘要

BACKGROUND: Accurate bleeding risk stratification after percutaneous coronary intervention is important for treatment individualization. However, there is still an unmet need for a more precise and standardized identification of patients at high bleeding risk. We derived and validated a novel bleeding risk score by augmenting the Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy (PRECISE-DAPT) score with the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria. METHODS: The derivation cohort comprised 29 188 patients undergoing percutaneous coronary intervention, of whom 1136 (3.9%) had Bleeding Academic Research Consortium (BARC) 3 or 5 bleeding at 1 year, from 4 contemporary real-world registries and the XIENCE V USA trial. The PRECISE-DAPT score was refitted with a Fine-Gray model in the derivation cohort and extended with the ARC-HBR criteria. The primary outcome was BARC 3 or 5 bleeding within 1 year. Independent predictors of BARC 3 or 5 bleeding were selected at multivariable analysis ( P <0.01). The discrimination of the score was internally assessed with apparent validation and cross-validation. The score was externally validated in 4578 patients from the MASTER DAPT trial (Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen) and 5970 patients from the STOPDAPT-2 (Short and Optimal Duration of Dual Antiplatelet Therapy-2) total cohort. RESULTS: The PRECISE-HBR score (age, estimated glomerular filtration rate, hemoglobin, white blood cell count, previous bleeding, oral anticoagulation, and ARC-HBR criteria) showed an area under the curve (AUC) for 1-year BARC 3 or 5 bleeding of 0.73 (95% CI, 0.71–0.74) at apparent validation, 0.72 (95% CI, 0.70–0.73) at cross-validation, 0.74 (95% CI, 0.68–0.80) in MASTER DAPT, and 0.73 (95% CI, 0.66–0.79) in STOPDAPT-2, with superior discrimination compared with PRECISE-DAPT (cross-validation: ΔAUC, 0.01; P =0.02; MASTER DAPT: ΔAUC, 0.05; P =0.004; STOPDAPT-2: ΔAUC, 0.02; P =0.20) and other risk scores. In the derivation cohort, a cutoff of 23 points identified 11 414 patients (39.1%) with a 1-year BARC 3 or 5 bleeding risk ≥4%. An alternative version of the score, including acute myocardial infarction on admission instead of white blood cell count, showed similar predictive ability. CONCLUSIONS: The PRECISE-HBR score is a contemporary, simple 7-item risk score to predict bleeding after percutaneous coronary intervention, offering a moderate improvement in discrimination over multiple existing scores. Further evaluation is required to assess its impact on clinical practice.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Mason发布了新的文献求助30
刚刚
九川发布了新的文献求助10
刚刚
MST发布了新的文献求助10
1秒前
yilisu完成签到,获得积分10
1秒前
英姑的应助被科研通管家采纳,获得10
1秒前
所所的应助被科研通管家采纳,获得10
1秒前
木瓜完成签到 ,获得积分10
1秒前
华仔的应助被科研通管家采纳,获得10
1秒前
打打的应助被科研通管家采纳,获得10
1秒前
2秒前
脑洞疼的应助被科研通管家采纳,获得30
2秒前
英姑的应助被科研通管家采纳,获得30
2秒前
小马甲的应助被科研通管家采纳,获得30
2秒前
molihuakai的应助被科研通管家采纳,获得10
2秒前
2秒前
852的应助被科研通管家采纳,获得10
2秒前
orixero的应助被科研通管家采纳,获得10
2秒前
SciGPT的应助被科研通管家采纳,获得10
2秒前
sandy完成签到,获得积分0
2秒前
2秒前
CarryLJR完成签到,获得积分10
2秒前
田様的应助被科研通管家采纳,获得10
3秒前
欣慰忆曼发布了新的文献求助10
3秒前
syvshc的应助被科研通管家采纳,获得10
3秒前
赵yy的应助被科研通管家采纳,获得10
3秒前
香蕉觅云的应助被科研通管家采纳,获得30
3秒前
3秒前
华仔的应助被科研通管家采纳,获得10
3秒前
852的应助被科研通管家采纳,获得10
3秒前
酷波er的应助被科研通管家采纳,获得10
3秒前
FashionBoy的应助被科研通管家采纳,获得10
3秒前
4秒前
Akim的应助被科研通管家采纳,获得10
4秒前
实验室的应助被科研通管家采纳,获得30
4秒前
英姑的应助被科研通管家采纳,获得10
4秒前
领导范儿的应助被科研通管家采纳,获得10
4秒前
无花果的应助被科研通管家采纳,获得30
4秒前
华仔的应助被科研通管家采纳,获得10
4秒前
南宫的应助被科研通管家采纳,获得10
4秒前
情怀的应助被Nhh采纳,获得10
5秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187652
求助须知:如何正确求助?哪些是违规求助? 9575758
关于积分的说明 21842805
捐赠科研通 7785538
什么是DOI,文献DOI怎么找? 3435073
关于科研通互助平台的介绍 2559480
邀请新用户注册赠送积分活动 2481963